• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便脂质谱作为脂肪消化不良、吸收不良和微生物群的新标志物。

Faecal lipid profile as a new marker of fat maldigestion, malabsorption and microbiota.

作者信息

Asensio-Grau Andrea, Ferriz-Jordán Miguel, Hervás David, Heredia Ana, García-Hernández Jorge, Garriga María, Masip Etna, Carmen Collado M, Andrés Ana, Ribes-Koninckx Carmen, Calvo-Lerma Joaquim

机构信息

Institute of Food Engineering (FoodUPV). Polytechnic University of València, 46022, València, Spain.

Joint Research Unit NutriCuraPDig, València, Spain.

出版信息

Pediatr Res. 2024 Dec;96(7):1794-1802. doi: 10.1038/s41390-024-03209-0. Epub 2024 May 22.

DOI:10.1038/s41390-024-03209-0
PMID:38778229
Abstract

BACKGROUND

Fat malabsorption in children with cystic fibrosis (CF) leads to poor nutritional status and altered colonic microbiota. This study aimed at establishing the faecal lipid profile in children with CF, and exploring associations between the faecal lipidome and microbiota.

METHODS

Cross-sectional observational study with children with CF and an age-matched control group. Faecal lipidome was analysed by UHLC-HRMS and microbiota profiling by 16S rRNA amplicon sequencing.

RESULTS

Among 234 identified lipid species, five lipidome clusters (LC) were obtained with significant differences in triacylglycerols (TG), diacylglycerols (DG), monoacylglycerols (MG) and fatty-acids (FA): LC1 subjects with good digestion and absorption: low TG and low MG and FA; LC2 good digestion and poor absorption: low TG and high MG and FA; LC3 Mild digestion and poor absorption: intermediate TG and high MG and FA; LC4 poor digestion and absorption: high TG and high MG and FA; LC5 outliers. Bacteroidota and Verrucomicrobiota decreased over LC1-LC4, while Proteobacteria increased. Nutritional status indicators were significantly higher in LC1 and decreased over LC2-LC4.

CONCLUSION

Assessing faecal lipidome may be relevant to determine how dietary lipids are digested and absorbed. This new evidence might be a method to support targeted nutritional interventions towards reverting fat maldigestion or malabsorption.

IMPACT

Lipidomic analysis enabled the identification of the lipid species related to maldigestion (triglycerides) or malabsorption (monoglycerides and fatty acids). Children with cystic fibrosis can be grouped depending on the faecal lipidome profile related to dietary fat maldigestion or malabsorption. The lipidome profile in faeces is related to the composition of microbiota and nutritional status indicators.

摘要

背景

囊性纤维化(CF)患儿的脂肪吸收不良会导致营养状况不佳和结肠微生物群改变。本研究旨在确定CF患儿的粪便脂质谱,并探索粪便脂质组与微生物群之间的关联。

方法

对CF患儿和年龄匹配的对照组进行横断面观察研究。通过超高效液相色谱-高分辨率质谱法分析粪便脂质组,并通过16S rRNA扩增子测序分析微生物群特征。

结果

在234种已鉴定的脂质种类中,获得了五个脂质组簇(LC),其甘油三酯(TG)、甘油二酯(DG)、甘油单酯(MG)和脂肪酸(FA)存在显著差异:LC1为消化吸收良好的受试者:低TG、低MG和FA;LC2为消化良好但吸收不良:低TG、高MG和FA;LC3为轻度消化和吸收不良:中等TG、高MG和FA;LC4为消化和吸收不良:高TG、高MG和FA;LC5为异常值。拟杆菌门和疣微菌门在LC1-LC4中减少,而变形菌门增加。营养状况指标在LC1中显著更高,并在LC2-LC4中降低。

结论

评估粪便脂质组可能与确定膳食脂质的消化和吸收方式相关。这一新证据可能是一种支持针对性营养干预以纠正脂肪消化或吸收不良的方法。

影响

脂质组学分析能够识别与消化不良(甘油三酯)或吸收不良(甘油单酯和脂肪酸)相关的脂质种类。囊性纤维化患儿可根据与膳食脂肪消化或吸收不良相关的粪便脂质组特征进行分组。粪便中的脂质组特征与微生物群组成和营养状况指标相关。

相似文献

1
Faecal lipid profile as a new marker of fat maldigestion, malabsorption and microbiota.粪便脂质谱作为脂肪消化不良、吸收不良和微生物群的新标志物。
Pediatr Res. 2024 Dec;96(7):1794-1802. doi: 10.1038/s41390-024-03209-0. Epub 2024 May 22.
2
Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.胃造口喂养的囊性纤维化患者中13C标记三棕榈酸甘油酯的消化和吸收不良
Clin Nutr. 2004 Jun;23(3):347-53. doi: 10.1016/j.clnu.2003.08.002.
3
Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.新型口服结构化脂肪补充剂治疗囊性纤维化儿童的残余脂肪吸收不良和生长改善:一项随机对照试验。
PLoS One. 2020 May 8;15(5):e0232685. doi: 10.1371/journal.pone.0232685. eCollection 2020.
4
Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.挪威西部囊性纤维化患者的粪便弹性蛋白酶-1和脂溶性维生素谱
Eur J Nutr. 2002 Aug;41(4):148-52. doi: 10.1007/s00394-002-0369-z.
5
Association between faecal pH and fat absorption in children with cystic fibrosis on a controlled diet and enzyme supplements dose.在接受饮食控制和酶补充剂量治疗的囊性纤维化儿童中,粪便 pH 值与脂肪吸收之间的关系。
Pediatr Res. 2021 Jan;89(1):205-210. doi: 10.1038/s41390-020-0860-3. Epub 2020 Apr 4.
6
Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.囊性纤维化患者粪便胆汁酸和膳食残渣排泄情况:年龄组差异
J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):296-300. doi: 10.1097/00005176-199809000-00005.
7
Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.接受酶替代疗法的囊性纤维化患者出现脂肪吸收不良是由于长链脂肪酸的肠道吸收受损。
Am J Clin Nutr. 1999 Jan;69(1):127-34. doi: 10.1093/ajcn/69.1.127.
8
Estimation of the 3-day faecal fat excretion and fat concentration as a differential test of malabsorption and maldigestion.
Scand J Gastroenterol. 1987 Jan;22(1):91-6. doi: 10.3109/00365528708991863.
9
Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.粪便弹性蛋白酶1检测在胰腺消化功能不良或肠道吸收不良患者中的诊断准确性:意大利儿科学会胃肠病学和肝病学协作研究
Dig Dis Sci. 2001 Jun;46(6):1335-42. doi: 10.1023/a:1010687918252.
10
Fecal fat and nitrogen in healthy children and in children with malabsorption or maldigestion.健康儿童以及患有吸收不良或消化不良的儿童的粪便脂肪和氮含量。
Pediatrics. 1970 Nov;46(5):690-5.

本文引用的文献

1
Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers.开始腹膜透析的患者的脂质谱表明,心血管风险增加超出了经典的血脂生物标志物。
Sci Rep. 2022 Sep 30;12(1):16394. doi: 10.1038/s41598-022-20757-9.
2
What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?我们对囊性纤维化中的微生物群了解多少?益生菌和益生元有作用吗?
Nutrients. 2022 Jan 22;14(3):480. doi: 10.3390/nu14030480.
3
Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.
肠功能和转运与囊性纤维化中的肠道微生物失调有关。
J Cyst Fibros. 2022 May;21(3):506-513. doi: 10.1016/j.jcf.2021.11.014. Epub 2021 Dec 8.
4
The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status.高效 CFTR 调节剂对生长和营养状况的影响。
Nutrients. 2021 Aug 24;13(9):2907. doi: 10.3390/nu13092907.
5
The Gut-Lung Axis in Cystic Fibrosis.囊性纤维化中的肠-肺轴。
J Bacteriol. 2021 Sep 23;203(20):e0031121. doi: 10.1128/JB.00311-21. Epub 2021 Aug 2.
6
Drug therapies for reducing gastric acidity in people with cystic fibrosis.用于降低囊性纤维化患者胃酸的药物治疗。
Cochrane Database Syst Rev. 2021 Apr 27;4(4):CD003424. doi: 10.1002/14651858.CD003424.pub5.
7
Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations.连接肠道微生物群与脂质代谢:超越关联性研究
Metabolites. 2021 Jan 15;11(1):55. doi: 10.3390/metabo11010055.
8
Clinical evaluation of an evidence-based method based on food characteristics to adjust pancreatic enzyme supplements dose in cystic fibrosis.基于食物特性调整囊性纤维化患者胰酶补充剂剂量的循证方法的临床评估
J Cyst Fibros. 2021 Sep;20(5):e33-e39. doi: 10.1016/j.jcf.2020.11.016. Epub 2020 Dec 2.
9
Fecal calprotectin in healthy children aged 4-16 years.4至16岁健康儿童的粪便钙卫蛋白
Sci Rep. 2020 Nov 25;10(1):20565. doi: 10.1038/s41598-020-77625-7.
10
Dietary fat, bile acid metabolism and colorectal cancer.饮食中的脂肪、胆汁酸代谢与结直肠癌。
Semin Cancer Biol. 2021 Aug;73:347-355. doi: 10.1016/j.semcancer.2020.10.003. Epub 2020 Oct 16.